Vaccinex, Inc. (VCNX)

USD 1.0

(66.67%)

Revenue Summary of Vaccinex, Inc.

  • Vaccinex, Inc.'s latest annual revenue in 2023 was 570 Thousand USD , up 470.0% from previous year.
  • Vaccinex, Inc.'s latest quarterly revenue in 2024 Q2 was 232 Thousand USD , up 123.08% from previous quarter.
  • Vaccinex, Inc. reported a annual revenue of 100 Thousand USD in annual revenue 2022, down -88.89% from previous year.
  • Vaccinex, Inc. reported a annual revenue of 900 Thousand USD in annual revenue 2021, up 1700.0% from previous year.
  • Vaccinex, Inc. reported a quarterly revenue of 232 Thousand USD for 2024 Q2, up 123.08% from previous quarter.
  • Vaccinex, Inc. reported a quarterly revenue of 570 Thousand USD for 2023 FY, up 470.0% from previous quarter.

Annual Revenue Chart of Vaccinex, Inc. (2023 - 2016)

Historical Annual Revenue of Vaccinex, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 570 Thousand USD 470.0%
2022 100 Thousand USD -88.89%
2021 900 Thousand USD 1700.0%
2020 50 Thousand USD -90.44%
2019 523 Thousand USD -27.76%
2018 724 Thousand USD 704.44%
2017 90 Thousand USD -71.52%
2016 316 Thousand USD 0.0%

Peer Revenue Comparison of Vaccinex, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD -178.991%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -14150.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 9.967%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -432.71%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.005%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -768.214%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD -7.547%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.093%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 95.268%
Trevena, Inc. 3.12 Million USD 81.76%
Vaxxinity, Inc. - USD -Infinity%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -1961.483%